|

Ribociclib 200Mg Oral Tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Forward Pharmaceuticals Co., Ltd.1

Indications

  • Locally Advanced Breast Cancer (LABC)1
  • ER+ Breast Cancer1
  • Breast Cancer Stage II1
  • Breast Cancer Stage I1
  • Metastatic Breast Cancer1

Other1 trial

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.